#Japan #AI Technology #Tokyo #Kirin #FANCL

Innovation in Supplement Development

In a groundbreaking collaboration, Fancl Corporation and Kirin Holdings Company have announced the joint development of an AI-powered tablet design system specifically tailored for pharmaceutical supplements. Utilizing extensive formulation data accumulated over years of research, this new tool aims to revolutionize how supplements are designed, reducing reliance on traditional methods that depend heavily on seasoned researchers' expertise and iterative trial and error.

The Need for Efficiency in Tablet Design

Tablet design is a complex process that requires meeting multiple criteria such as swallowability, durability during transportation, and dissolvability in the human body. These properties often affect each other, which creates challenges in crafting the optimal formulation. In the past, achieving the right balance necessitated numerous prototypes, leading to prolonged development timelines. Recognizing this challenge, the collaboration set out to leverage AI technology to expedite the formulation process.

Methodology and Optimized Results

The newly developed AI leverages machine learning to analyze historical research and manufacturing data. By predicting multiple factors—such as how easy a tablet is to swallow, its toughness to withstand transportation, and its rate of dissolution in the body—the AI can assess thousands, even tens of thousands, of possible formulation combinations quickly and accurately. This level of analysis would be virtually impossible manually but is made feasible through AI technology.

As a result, the AI can identify the best possible formulation, leading to improved product quality (e.g., faster dissolution, smaller size for easier swallowing), stabilization of product quality by ensuring consistent design across all batches, a significant reduction in development time, and less raw material waste.

Future Perspectives

At Fancl, the guiding principle has always been to deliver only the essential ingredients that provide real value to our customers. By harnessing this new technology, we aspire to transform the supplement tablet design process from a traditional trial-and-error approach into a data-driven model that enhances not only swallowability but also the effectiveness within the body.

Moving forward, Fancl and Kirin are committed to capitalizing on the synergy between human creativity and AI capabilities to develop high-quality, easy-to-swallow tablet formulations while continually enhancing the overall value of their products.

Academic Recognition

The results of this significant research collaboration are set to be published in the international scientific journal "Pharmaceutics" in April 2026, under the title "Application of AI in Tablet Development: An Integrated Machine Learning Framework for Pre-Formulation Property Prediction." The authors, including Masugu Hamaguchi, Tomoki Adachi, and Noriyoshi Arai, will be recognized for showcasing the novelty and effectiveness of AI-powered formulation design.

In conclusion, this collaboration between Fancl and Kirin marks a pivotal step forward in supplement formulation, integrating advanced technology with deep-rooted industry knowledge to create the next generation of supplements that prioritize consumer needs.